Your session is about to expire
← Back to Search
Contact Lens
test/control/control for Visual Acuity
N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-week follow-up
Awards & highlights
Study Summary
This will be a 4-visit, randomized, controlled, single-masked, bilateral wear, dispensing, 2-treament, 2-sequence, 3-period crossover study to evalulate overall vision and comfort..
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-week follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-week follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CLUE Comfort Score
Trial Design
2Treatment groups
Experimental Treatment
Group I: test/control/controlExperimental Treatment2 Interventions
Eligible subjects that are habitual contact lens wearers will be randomized into the (test/control/control) sequence and will wear two different study lenses one at a time bilaterally over three wear periods.
Group II: control/test/testExperimental Treatment2 Interventions
Eligible subjects that are habitual contact lens wearers will be randomized into the (control/test/test) sequence and will wear two different study lenses one at a time bilaterally over three wear periods.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
soft contact lens in senofilcon A (C3) with HEVL-blocking chromophore
2022
N/A
~130
ACUVUE OASYS 1-Day for Astigmatism
2022
N/A
~280
Find a Location
Who is running the clinical trial?
Johnson & Johnson Vision Care, Inc.Lead Sponsor
216 Previous Clinical Trials
25,435 Total Patients Enrolled
87 Trials studying Visual Acuity
8,650 Patients Enrolled for Visual Acuity
Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.
44 Previous Clinical Trials
4,309 Total Patients Enrolled
33 Trials studying Visual Acuity
3,679 Patients Enrolled for Visual Acuity
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger